• Partnering with Genoa
  • People-first Pharmacy Care

Retail pharmacy challenges highlight the need for reliable, uninterrupted pharmacy care

Jul 8th, 2024

Inconsistent hours, long lines and poor customer service have been an all-too-familiar experience for retail pharmacy consumers in recent years. Ongoing staffing shortages and increased demand for pharmacy support – two factors which have yet to ease up – create interruptions and barriers to care that could have real consequences for the people who need that care most.

During this ongoing crisis, consumers and organizations that have partnered with Genoa Healthcare have continued to receive the same consistent, high-touch pharmacy care they’ve come to expect. Genoa’s hours of operation have remained consistent and often align with those of its partner clinics. Genoa pharmacists are part of the consumer’s care team, collaborating closely with providers and prescribers to ensure consumer needs are met. The organization’s pharmacists even provide prescribers with proactive information about drug availability, helping to ease issues amid nationwide drug shortages. And Genoa takes pride in prioritizing outcomes – not patient volume – taking the time to get to know each consumer personally, ensuring all their individual pharmacy care needs are met.

This consistency in care and service results in high satisfaction scores, with a consumer net promoter score of 93 and provider net promoter score of 85.[1] Providers and consumers can rest assured knowing the services and high-quality care they’ve come to expect from Genoa will continue uninterrupted.

Is the service from your community retail pharmacies causing unnecessary frustrations for your consumers and staff or have pharmacies in your area recently closed? Genoa can help. Contact us today and we’ll be in touch.

Let’s connect

Fill out the form below and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

[1] Genoa Healthcare. (2024) Bi-annual net promoter score survey. Unpublished internal company document.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...